Platinum Investment Management LTD Bio N Tech Se Transaction History

Platinum Investment Management LTD

$2.16 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$88.96 - $112.35 $3.36 Million - $4.24 Million	-37,737 Reduced 47.44%	41,815 $3.86 Million
Q4 2023 Feb 13, 2024	BUY	$90.91 - $112.75 $1.02 Million - $1.26 Million	11,214 Added 16.41%	79,552 $8.4 Million
Q3 2023 Nov 02, 2023	BUY	$98.5 - $125.08 $246,250 - $312,700	2,500 Added 3.8%	68,338 $7.42 Million
Q2 2023 Aug 10, 2023	BUY	$102.58 - $129.66 $256,450 - $324,150	2,500 Added 3.95%	65,838 $7.11 Million
Q1 2023 May 11, 2023	BUY	$122.57 - $153.67 $3.04 Million - $3.81 Million	24,811 Added 64.4%	63,338 $7.89 Million
Q4 2022 Feb 13, 2023	BUY	$118.43 - $186.05 $4.56 Million - $7.17 Million	38,527 New	38,527 $5.79 Million
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $945,865 - $1.74 Million	-7,492 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$205.93 - $447.23 $11.2 Million - $24.4 Million	-54,567 Reduced 87.93%	7,492 $2.05 Million
Q2 2021 Aug 11, 2021	SELL	$113.32 - $241.49 $19.1 Million - $40.6 Million	-168,208 Reduced 73.05%	62,059 $13.9 Million
Q1 2021 May 13, 2021	BUY	$85.73 - $119.5 $2.24 Million - $3.12 Million	26,128 Added 12.8%	230,267 $25.1 Million
Q4 2020 Feb 12, 2021	SELL	$72.71 - $129.54 $7.49 Million - $13.4 Million	-103,058 Reduced 33.55%	204,139 $16.6 Million
Q3 2020 Nov 13, 2020	SELL	$57.81 - $104.17 $3.5 Million - $6.31 Million	-60,591 Reduced 16.47%	307,197 $21.3 Million
Q2 2020 Aug 06, 2020	SELL	$38.58 - $66.74 $3.93 Million - $6.79 Million	-101,778 Reduced 21.67%	367,788 $24.5 Million
Q4 2019 Feb 13, 2020	BUY	$12.75 - $36.91 $5.99 Million - $17.3 Million	469,566 New	469,566 $14.2 Million

Others Institutions Holding BNTX

# of Institutions

360

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $30B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Account